Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy?-Reference-Cited by-同舟云学术

Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy?

Published:2018-11-14 Issue:3 Volume:125 Page:434-441
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vidal Adriana C.¹,Howard Lauren E.¹²³,De Hoedt Amanda²,Kane Christopher J.⁴,Terris Martha K.⁵⁶,Aronson William J.⁷⁸,Cooperberg Matthew R.⁹,Amling Christopher L.¹⁰,Lechpammer Stanislav¹¹,Flanders Scott C.¹²,Freedland Stephen J.¹²

Affiliation:

1. Division of Urology, Department of Surgery Cedars‐Sinai Medical Center Los Angeles California

2. Urology Section Veterans Affairs Medical Center Durham North Carolina

3. Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina

4. Urology Department University of California‐San Diego Health System San Diego California

5. Section of Urology Veterans Affairs Medical Center Augusta Georgia

6. Section of Urology Medical College of Georgia Augusta Georgia

7. Urology Section, Department of Surgery Veterans Affairs Greater Los Angeles Healthcare System Los Angeles California

8. Department of Urology University of California‐Los Angeles School of Medicine Los Angeles California

9. Department of Urology University of California‐Los Angeles Helen Diller Family Comprehensive Cancer Center San Francisco California

10. Division of Urology Oregon Health Sciences University Portland Oregon

11. Medical Affairs Oncology Pfizer, Inc San Francisco California

12. Health Economics and Clinical Outcomes Research‐Oncology Astellas Pharma, Inc Northbrook Illinois

Funder

National Institutes of Health

Georgia Cancer Coalition

American Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31808

Reference19 articles.

1. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010

2. Epidemiology of prostate cancer: current status;Tao ZQ;Eur Rev Med Pharmacol Sci,2015

3. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period

4. Cancer statistics, 2017

5. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with biochemical recurrence of prostate cancer post radical prostatectomy;South African Journal of Oncology;2024-05-31

2. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients;JAMA Network Open;2023-01-11

3. Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2021-11-03

4. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications;Medicines;2019-07-30